|
1
|
Pittenger MF, Mackay AM, Beck SC, Jaiswal
RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and
Marshak DR: Multilineage potential of adult human mesenchymal stem
cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
El Omar R, Beroud J, Stoltz JF, Menu P,
Velot E and Decot V: Umbilical cord mesenchymal stem cells: The new
gold standard for mesenchymal stem cell-based therapies? Tissue Eng
Part B Rev. 20:523–544. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nuschke A: Activity of mesenchymal stem
cells in therapies for chronic skin wound healing. Organogenesis.
10:29–37. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ra JC, Kang SK, Shin IS, Park HG, Joo SA,
Kim JG, Kang BC, Lee YS, Nakama K, Piao M, et al: Stem cell
treatment for patients with autoimmune disease by systemic infusion
of culture-expanded autologous adipose tissue derived mesenchymal
stem cells. J Transl Med. 9:1812011.PubMed/NCBI
|
|
5
|
Bhansali A, Asokumar P, Walia R, Bhansali
S, Gupta V, Jain A, Sachdeva N, Sharma RR, Marwaha N and Khandelwal
N: Efficacy and safety of autologous bone marrow-derived stem cell
transplantation in patients with type 2 diabetes mellitus: A
randomized placebo-controlled study. Cell Transplant. 23:1075–1085.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Knaän-Shanzer S: Concise review: The
immune status of mesenchymal stem cells and its relevance for
therapeutic application. Stem Cells. 32:603–608. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Castro-Manrreza ME and Montesinos JJ:
Immunoregulation by mesenchymal stem cells: Biological aspects and
clinical applications. J Immunol Res. 2015:3949172015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vaes B, Van't Hof W, Deans R and Pinxteren
J: Application of MultiStem(®) allogeneic cells for
immunomodulatory therapy: Clinical progress and Pre-clinical
challenges in prophylaxis for graft versus host disease. Front
Immunol. 3:3452012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang L, Xiang J and Li G: The uncertain
role of unmodified mesenchymal stem cells in tumor progression:
What master switch? Stem Cell Res Ther. 4:222013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hong IS, Lee HY and Kang KS: Mesenchymal
stem cells and cancer: Friends or enemies? Mutat Res. 768:98–106.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang X, Hou J, Han Z, Wang Y, Hao C, Wei L
and Shi Y: One cell, multiple roles: Contribution of mesenchymal
stem cells to tumor development in tumor microenvironment. Cell
Biosci. 3:52013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ning H, Yang F, Jiang M, Hu L, Feng K,
Zhang J, Yu Z, Li B, Xu C, Li Y, et al: The correlation between
cotransplantation of mesenchymal stem cells and higher recurrence
rate in hematologic malignancy patients: Outcome of a pilot
clinical study. Leukemia. 22:593–599. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nomoto-Kojima N, Aoki S, Uchihashi K,
Matsunobu A, Koike E, Ootani A, Yonemitsu N, Fujimoto K and Toda S:
Interaction between adipose tissue stromal cells and gastric cancer
cells in vitro. Cell Tissue Res. 344:287–298. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Seo SH, Kim KS, Park SH, Suh YS, Kim SJ,
Jeun SS and Sung YC: The effects of mesenchymal stem cells injected
via different routes on modified IL-12-mediated antitumor activity.
Gene Ther. 18:488–495. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sarmadi VH, Tong CK, Vidyadaran S,
Abdullah M, Seow HF and Ramasamy R: Mesenchymal stem cells inhibit
proliferation of lymphoid origin haematopoietic tumour cells by
inducing cell cycle arrest. Med J Malaysia. 65:209–214.
2010.PubMed/NCBI
|
|
16
|
Carrade DD, Lame MW, Kent MS, Clark KC,
Walker NJ and Borjesson DL: Comparative analysis of the
immunomodulatory properties of equine Adult-derived mesenchymal
stem cells(). Cell Med. 4:1–11. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ren G, Zhang L, Zhao X, Xu G, Zhang Y,
Roberts AI, Zhao RC and Shi Y: Mesenchymal stem cell-mediated
immunosuppression occurs via concerted action of chemokines and
nitric oxide. Cell Stem Cell. 2:141–150. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu J, Yang Z, Wang J, Tang Y, Liu H, Zhang
B and Chen H: Infusion of Trx-1-overexpressing hucMSC prolongs the
survival of acutely irradiated NOD/SCID mice by decreasing
excessive inflammatory injury. PLoS One. 8:e782272013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jones SA, Scheller J and Rose-John S:
Therapeutic strategies for the clinical blockade of IL-6/gp130
signaling. J Clin Invest. 121:3375–3383. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Batsali AK, Kastrinaki MC, Papadaki HA and
Pontikoglou C: Mesenchymal stem cells derived from Wharton's Jelly
of the umbilical cord: Biological properties and emerging clinical
applications. Curr Stem Cell Res Ther. 8:144–155. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ramasamy R, Lam EW, Soeiro I, Tisato V,
Bonnet D and Dazzi F: Mesenchymal stem cells inhibit proliferation
and apoptosis of tumor cells: Impact on in vivo tumor growth.
Leukemia. 21:304–310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fonseka M, Ramasamy R, Tan BC and Seow HF:
Human umbilical cord blood-derived mesenchymal stem cells
(hUCB-MSC) inhibit the proliferation of K562 (human
erythromyeloblastoid leukaemic cell line). Cell Biol Int.
36:793–801. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cetintas Bozok V, Aktug H, Oltulu F,
Keskinoglu A, Del Castello Erer B and Taskiran D: The effects of
mesenchymal stem cells on lymphoblastic leukemia cell
proliferation. J BUON. 19:1006–1017. 2014.PubMed/NCBI
|
|
24
|
Zhu Y, Sun Z, Han Q, Liao L, Wang J, Bian
C, Li J, Yan X, Liu Y, Shao C and Zhao RC: Human mesenchymal stem
cells inhibit cancer cell proliferation by secreting DKK-1.
Leukemia. 23:925–933. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rosean TR, Tompkins VS, Tricot G, Holman
CJ, Olivier AK, Zhan F and Janz S: Preclinical validation of
interleukin 6 as a therapeutic target in multiple myeloma. Immunol
Res. 59:188–202. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Klein B, Tarte K, Jourdan M, Mathouk K,
Moreaux J, Jourdan E, Legouffe E, De Vos J and Rossi JF: Survival
and proliferation factors of normal and malignant plasma cells. Int
J Hematol. 78:106–113. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Voorhees PM, Manges RF, Sonneveld P,
Jagannath S, Somlo G, Krishnan A, Lentzsch S, Frank RC, Zweegman S,
Wijermans PW, et al: A phase 2 multicentre study of siltuximab, an
anti-interleukin-6 monoclonal antibody, in patients with relapsed
or refractory multiple myeloma. Br J Haematol. 161:357–366. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Matsuyama Y, Nagashima T, Honne K, Kamata
Y, Iwamoto M, Okazaki H, Sato K, Ozawa K and Minota S: Successful
treatment of a patient with rheumatoid arthritis and IgA-k multiple
myeloma with tocilizumab. Intern Med. 50:639–642. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ahn JO, Chae JS, Coh YR, Jung WS, Lee HW,
Shin IS, Kang SK and Youn HY: Human adipose tissue-derived
mesenchymal stem cells inhibit T-cell lymphoma growth in vitro and
in vivo. Anticancer Res. 34:4839–4847. 2014.PubMed/NCBI
|
|
30
|
Medina DJ, Goodell L, Glod J, Gelinas C,
Rabson AB and Strair RK: Mesenchymal stromal cells protect mantle
cell lymphoma cells from spontaneous and drug-induced apoptosis
through secretion of B-cell activating factor and activation of the
canonical and non-canonical nuclear factor kB pathways.
Haematologica. 97:1255–1263. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guney N, Soydinc HO, Basaran M, Bavbek S,
Derin D, Camlica H, Yasasever V and Topuz E: Serum levels of
interleukin-6 and interleukin-10 in Turkish patients with
aggressive non-Hodgkin's lymphoma. Asian Pac J Cancer Prev.
10:669–674. 2009.PubMed/NCBI
|
|
32
|
Kovacs E: Interleukin-6 leads to
interleukin-10 production in several human multiple myeloma cell
lines. Does interleukin-10 enhance the proliferation of these
cells? Leuk Res. 34:912–916. 2010. View Article : Google Scholar : PubMed/NCBI
|
